Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.860
-0.090 (-2.28%)
At close: Feb 4, 2026, 4:00 PM EST
3.860
0.00 (0.00%)
After-hours: Feb 4, 2026, 4:00 PM EST
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $36.49 million as of February 4, 2026.
Market Cap
36.49M
Enterprise Value
824.31K
1-Year Change
n/a
Ranking
Category
Stock Price
$3.86
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $36.49M, a decrease of -78.62%. That is a compound annual growth rate of -85.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 37.06M | -8.14% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 39.26M |
| Anebulo Pharmaceuticals | 39.03M |
| Generation Bio Co. | 38.47M |
| Actinium Pharmaceuticals | 37.44M |
| Xilio Therapeutics | 37.39M |
| RenovoRx | 37.02M |
| Atara Biotherapeutics | 36.34M |
| Celularity | 35.47M |